Weight Loss Clinical Trials in California

24 recruiting studies across 6 cities

Browse by City

Los Angeles

All Trials in California

Phase

Trial	Phase	Sponsor	Dist.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue	Phase 2/3	Pfizer	<1 mi
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy	Phase 2	Endevica Bio	<1 mi
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant	N/A	Jonsson Comprehensive Cancer Center	<1 mi
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy	Phase 2	Stephen Freedland	<1 mi
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients	N/A	Nitinotes Surgical Ltd.	<1 mi
BrainWeighve App Feasibility Study	N/A	University of California, Los Angeles	<1 mi
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)	—	Cedars-Sinai Medical Center	<1 mi
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients	N/A	University of California, Los Angeles	<1 mi
Benefits of Endoscopic Bariatric Procedures	N/A	Cedars-Sinai Medical Center	<1 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea	Phase 3	Novo Nordisk A/S	<1 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus	Phase 2	Corxel Pharmaceuticals	<1 mi
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia	Phase 1	AVEO Pharmaceuticals, Inc.	7 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	7 mi
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse	Phase 4	Kalpna Kay Durairaj, MD, FACS	9 mi
Time Restricted Eating in Sleep Apnea	Early 1	University of California, San Diego	11 mi
Family, Responsibility, Education, Support, and Health for Food Responsiveness	N/A	University of California, San Diego	11 mi
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients	Phase 2	University of California, San Diego	11 mi
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass	N/A	Boston Scientific Corporation	17 mi
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss	Phase 3	Novo Nordisk A/S	21 mi
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	21 mi
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists	—	Cytrellis Biosystems, Inc.	25 mi
Addressing Diabetes by Elevating Access to Nutrition	N/A	Stanford University	25 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	28 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.